ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $10,005,000 | +46.6% | 850,000 | +70.0% | 0.40% | +45.2% |
| Q1 2019 | $6,825,000 | +232.9% | 500,000 | +150.0% | 0.28% | +267.1% |
| Q4 2018 | $2,050,000 | -64.2% | 200,000 | -60.0% | 0.08% | -11.6% |
| Q4 2017 | $5,725,000 | -6.5% | 500,000 | 0.0% | 0.09% | -18.9% |
| Q3 2017 | $6,125,000 | +78.3% | 500,000 | +66.7% | 0.11% | +76.7% |
| Q2 2017 | $3,435,000 | -45.0% | 300,000 | 0.0% | 0.06% | -56.8% |
| Q1 2017 | $6,240,000 | – | 300,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |